athenahealth Reports Third Quarter Fiscal Year 2018 Results

Go back to athenahealth Reports Third Quarter Fiscal Year 2018 Results

athenahealth (ATHN) PT Lowered to $142 at KeyBanc Following 3Q

November 12, 2018 7:52 AM EST

KeyBanc analyst Donald Hooker lowered the price target on athenahealth (NASDAQ: ATHN) to $142.00 (from $170.00) while maintaining a Overweight rating following the company's 3Q. ATHN reported weak 3Q18 top-line metrics with soft bookings of only $38M (down ~34% y/y) and revenues lagging consensus ($330M vs.... More

UPDATE: Athenahealth (ATHN) Tops Q3 EPS by 8c, Updates FY Guidance

November 9, 2018 4:02 PM EST

(Updated - November 9, 2018 4:09 PM EST)

Athenahealth (NASDAQ: ATHN) reported Q3 EPS of $1.08, $0.08 better than the analyst estimate of $1.00. Revenue for the quarter came in at $331.4 million versus the consensus estimate of $336.64 million.

Athenahealth sees FY revenue of $1.34 to $1.37 billion vs the... More